CDC COVID-19 Response Team and colleagues

Mark Thompson of the CDC COVID-19 Response Team and colleagues also demonstrated that the vaccines were highly efficient at lowering the viral load, febrile symptoms, and the duration of illness in people who acquired breakthrough infections despite being vaccinated.

The latest Covid-19 vaccines from Pfizer and Moderna

The latest Covid-19 vaccines from Pfizer and Moderna tend to be exceptionally effective at avoiding severe illness.

More than 100,000 Americans are in COVID-19 hospital

More than 100,000 Americans are in COVID-19 hospital, while the nation has recorded its one-worst daily death toll since the pandemic began.

The CDC has updated its guidelines on the spread of COVID-19

The CDC has updated its guidelines on the spread of COVID-19.

Both the Pfizer vaccine and the Moderna vaccine were developed with new technology

Both the Pfizer vaccine and the Moderna vaccine were developed with new technology that uses messenger RNA.

Masks in public places

Coronavirus Covid-19 increased by 467 percent in Kansas counties, requiring masks in public places.

Indoor behaviors do not all bear the same degree of risk, health experts say

According to the Centers for Disease Control and Prevention, these indoor behaviors are far more dangerous indoors during the pandemic.

Study: immunity from SARS-CoV-2 can last for at least six months

Study: immunity from SARS-CoV-2 can last for at least six months, or it may be longer, maybe a matter of years.

Danish study finds that face masks provide only limited protection

Danish study finds that face masks provide only limited protection against SARS-CoV-19 infection.

Patients with Type O or B blood spent less time in ICU than those with Type A or AB

Patients with Type O or B blood spent less time in ICU than those with Type A or AB.